NewsRx

Search our medical news database

Nanobiotechnology

NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update

Published in Medical Patent Business Week, November 16th, 2007

NanoLogix, Inc. (BULLETIN BOARD: NNLX) a nano-biotechnology company announces the date and venue for the Company's annual shareholder meeting.

The meeting will take place at 1 PM on 12/28/07 and will be held at the Company's Hubbard, Ohio office. A call-in number will be provided for questions to management. The number will be made available on our website two days prior to the meeting. Shareholders of record as of 11/23/07 will receive proxy statements.

Research and development continues with the prototype bioreactor at Welch's, with design and economic modeling proceeding for construction of the next generation of hydrogen bioreactors for both...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook